At a glance
This page lists additional expertise from other professionals that could be helpful for patients with PFAS exposure concerns.
Additional expertise
For patients with PFAS exposure concerns, other professionals can help gather useful exposure information, evaluate the patients, recommend exposure reduction methods, and develop a patient monitoring or treatment plan. For example,
- Board-certified clinicians specializing in occupational and environmental medicine, medical toxicology, or pediatric environmental health can assist in evaluating and managing patients exposed or potentially exposed to hazardous substances.
- Occupational health clinicians (often at work sites) have knowledge about workplace exposures and health issues and can provide context or guidance to workers and clinicians.
- State or local health/environmental departments have knowledge about documented environmental contamination and associated health issues. They can help determine whether/how to assess health risks. They can also assist with identifying water quality reports and how to get private wells tested.
ATSDR will continue to review the science and periodically update PFAS information for clinicians.
Content Source:
Agency for Toxic Substances and Disease Registry
- [ATSDR] Agency for Toxic Substances and Disease Registry. 2021. Toxicological profile for perfluoroalkyls. U.S. Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA [accessed 2023 May 4]. Available from: https://www.atsdr.cdc.gov/ToxProfiles/tp200.pdf
- [CDC] Centers for Disease Control and Prevention. 2023. National Report on Human Exposure to Environmental Chemicals. Centers for Disease Control and Prevention, Atlanta, GA [accessed 2023 May 4]. Available from: https://www.cdc.gov/exposurereport/index.html
- [NASEM] National Academies of Sciences, Engineering, and Medicine. 2022. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up. Washington, DC: The National Academies Press. Available from: https://nap.nationalacademies.org/catalog/26156/guidance-on-pfas-exposure-testing-and-clinical-follow-up